Kingdon Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-200,000
| Closed | -$2M | – | 72 |
|
|
2022
Q3 | $2M | Hold |
200,000
| – | – | 0.26% | 37 |
|
|
2022
Q2 | $1.98M | Hold |
200,000
| – | – | 0.34% | 47 |
|
|
2022
Q1 | $1.97M | Hold |
200,000
| – | – | 0.21% | 57 |
|
|
2021
Q4 | $1.95M | Hold |
200,000
| – | – | 0.22% | 56 |
|
|
2021
Q3 | $1.96M | Hold |
200,000
| – | – | 0.24% | 47 |
|
|
2021
Q2 | $1.97M | Buy |
+200,000
| New | +$1.97M | 0.23% | 51 |
|